KYOTO, Japan, Apr 2, 2026 - (JCN Newswire) - OMRON Healthcare Co., Ltd. today announced the launch of a randomized controlled ...

Study will explore early detection of atrial fibrillation to reduce stroke and heart failure risk through home blood pressure monitoringKYOTO, Japan, Apr 2, 2026 - (JCN Newswire) - OMRON Healthcare Co ...

Despite guideline recommendations, evidence for the use of non–vitamin K antagonist oral anticoagulant (NOAC) monotherapy in patients with atrial fibrillation after implantation of a drug-eluting ...

We conducted an international, open-label, randomized, blinded-outcome-assessment trial involving 1284 patients who had undergone successful catheter ablation for atrial fibrillation at least 1 year ...

The lead-I electrocardiogram (ECG) devices were assessed when they were used in addition to 12‑lead ECGs. Clinical experts advised that a 12‑lead ECG would still be used after lead-I ECGs to identify ...

Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation represents a ...

The external assessment group (EAG) did a systematic review to identify evidence on the diagnostic accuracy and clinical effectiveness of using the lead‑I ECG devices to detect atrial fibrillation.